Ramdev's 'Putrajeevak Beej' under scanner

Haryana has one of India's worst girl-boy ratios — in some villages men remain unmarried, and the preference for male children persists. Against that backdrop, a product name set off a national controversy.
Divya Pharmacy, the chain associated with Baba Ramdev, sold a medicine called "Putrajeevak Beej" — a name critics said promised women a male child, with Ramdev's followers openly describing it that way. The product and what its name implied came under media and parliamentary scrutiny.
Ramdev pushed back, insisting it was only an infertility drug. "The name has simply been derived from its scientific name, Putranjiva roxburghii Wall, and has got nothing to do with the promise of a son," he said. "Lying in the Parliament is a national crime."
Madhya Pradesh banned the product's sale anyway, saying it could return once Patanjali Yogpeeth changed the name. Ramdev refused to rename it but agreed to add a disclaimer.
The yoga guru, no stranger to controversy, also took a swipe at Samajwadi Party MP Jaya Bachchan — who had demanded a ban on his pharmacy products — saying she was doing so because she was "not getting any opportunity to act in movies these days."
Whatever the pharmacology, the episode underlined how a name alone can collide with India's deepest anxieties about the girl child.
Based on reporting by IBNLive and others, May 2015.
Related Stories

Jammu and Kashmir to boost girl child ratio
J&K's 2015 budget offered ₹1,000 a month for every newborn girl — maturing to ₹6.5 lakh at 21 — to fight the state's falling child sex ratio.

The Crown’s Hidden Mission: What Queen Elizabeth II Wanted and What Does King Charles Really Want in Canada
Charles III's 2025 throne speech echoes Elizabeth II's 1977 Ottawa visit — on monarchy, soft power, and royal speeches in a fracturing Canada.
How the U.S.-Saudi Oil Alliance Is Repeating in the Electric Economy: History Doesn't Repeat but It Rhymes
Oil alliances shaped the 20th century; battery minerals and rare earths are shaping the 21st. How the U.S. and Saudi Arabia are re-running the old playbook